Information provided in these publications, posters, and presentations is not considered medical advice and is not intended to promote the sale of any drug product.
Journal of Antimicrobial Chemotherapy
Oxford University Press
IDWeek 2020
Real World Multi-center Experience with Eravacycline for Complicated Infections
Infectious Diseases and Therapy
A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline
Journal of Antimicrobial Chemotherapy
In vitro activity of eravacycline against common ribotypes of Clostridioides difficile
International Journal of Antimicrobial Agents
Journal of Antimicrobial Chemotherapy
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
23rd Annual MAD-ID Meeting
Real-world Utilization of Eravacycline in the Outpatient Setting
Open Forum Infectious Diseases
Early Experience with Eravacycline for Complicated Infections
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
Open Forum Infectious Diseases
Expert Review of Anti-infectant Therapy
Eravacycline for the treatment of complicated intra-abdominal infections
IDWeek 2019
Clinical Therapeutics
Future Medicine
Antimicrobial Agents and Chemotherapy
22nd Annual MAD-ID Meeting
Efficacy of Eravacycline in Obese Patients: Pooled Analysis of IGNITE1 and IGNITE4
22nd Annual MAD-ID Meeting
Eravacycline is Effective in High-Risk Complicated Intra-Abdominal Infection Subgroups
22nd Annual MAD-ID Meeting
22nd Annual MAD-ID Meeting
Multi-Site Evaluation of Eravacycline MIC Test Strip (MTS) Compared to Broth Microdilution MICs
Antimicrobial Agents and Chemotherapy
Clinical Infectious Diagnosis
BMC Microbiology
Antimicrobial Agents and Chemotherapy
2018 ACCP Global Conference on Clinical Pharmacy
Efficacy of Eravacycline in Obese Patients: Pooled Anaysis of IGNITE1 and IGNITE4
2018 ACCP Global Conference on Clinical Pharmacy
Antimicrobial Agents and Chemotherapy
Journal of Antimicrobial Chemotherapy
Antimicrobicrobial Agents and Chemotherapy
Pharmacokinetics and Comprehensive Analysis of the Tissue Distribution of Eravacycline in Rabbits
ASM Microbe 2018
TP-6076 is active against bacterial isolates carrying emergent resistance types
Making a Difference in Infectious Diseases 2018 Meeting
Diagnostic Microbiology and Infectious Disease
International Journal of Antimicrobial Agents
Antimicrobial Agents and Chemotherapy
Antimicrobicrobial Agents and Chemotherapy
38th Surgical Infection Society Annual Meeting
38th Surgical Infection Society Annual Meeting
28th European Congress of Clinical Microbiology and Infectious Diseases
28th European Congress of Clinical Microbiology and Infectious Diseases
28th European Congress of Clinical Microbiology and Infectious Diseases
28th European Congress of Clinical Microbiology and Infectious Diseases
Eravacycline Is Active Against Bacterial Isolates Carrying Emergent Resistance Types
International Journal of Antimicrobial Agent
International Journal of Antimicrobial Agents
55th Infectious Diseases Society of America Annual Meeting
55th Infectious Diseases Society of America Annual Meeting
Antimicrobial Agents and Chemotherapy
Journal of Antimicrobial Chemotherapy
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
ASM Microbe
The Novel Fluorocycline TP-271 Is Efficacious in a Murine A baumannii Pneumonia Model
ASM Microbe
Pharmacokinetics of Eravacycline Following Intravenous Administration in Rabbits
27th European Congress of Clinical Microbiology and Infectious Diseases
27th European Congress of Clinical Microbiology and Infectious Diseases
27th European Congress of Clinical Microbiology and Infectious Diseases
27th European Congress of Clinical Microbiology and Infectious Diseases
27th European Congress of Clinical Microbiology and Infectious Diseases
27th European Congress of Clinical Microbiology and Infectious Diseases
27th European Congress of Clinical Microbiology and Infectious Diseases
26th European Congress of Clinical Microbiology and Infectious Diseases
54th Annual Meeting of the Infectious Diseases Society of America
54th Annual Meeting of the Infectious Diseases Society of America
Antimicrobial Agents and Chemotherapy
Eravacycline Is Active Against Bacterial Isolates Expressing the Polymyxin Resistance Gene mcr-1
Antimicrobial Agents and Chemotherapy
Eravacycline Pharmacokinetics and Challenges in Defining Humanized Exposure In Vivo
Antimicrobial Agents and Chemotherapy
Antibacterial Efficacy of Eravacycline In Vivo Against Gram-Positive and Gram-Negative Organisms
Antimicrobial Agents and Chemotherapy
36th Annual Meeting of Surgical Infection Society
26th European Congress of Clinical Microbiology and Infectious Diseases
26th European Congress of Clinical Microbiology and Infectious Diseases
26th European Congress of Clinical Microbiology and Infectious Diseases
26th European Congress of Clinical Microbiology and Infectious Diseases
Antimicrobial Agents and Chemotherapy
20th North American International Society for the Study of Xenobiotics Meeting
53rd Infectious Diseases Society of America Annual Meeting
53rd Infectious Diseases Society of America Annual Meeting
Activity of Eravacycline Against Anaerobic Bacteria from Europe Collected in 2013-2014
55th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
55th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
55th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
55th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
55th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
55th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
25th European Congress of Clinical Microbiology and Infectious Diseases
25th European Congress of Clinical Microbiology and Infectious Diseases
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
Antimicrobial Agents and Chemotherapy
Eravacycline (TP-434) Is Active In Vitro Against Biofilms Formed by Uropathogenic Escherichia coli
Antimicrobial Agents and Chemotherapy
54th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Efficacy of the Novel Fluorocycline TP-271 in a Mouse Model of Neisseria gonorrhoeae Infection
54th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
54th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
54th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
54th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
ASM General Meeting
24th European Congress of Clinical Microbiology and Infectious Diseases
24th European Congress of Clinical Microbiology and Infectious Diseases
24th European Congress of Clinical Microbiology and Infectious Diseases
24th European Congress of Clinical Microbiology and Infectious Diseases
Eravacycline Protects in a Bacillus anthracis-Infected New Zealand White Rabbit Treatment Model
28th European Congress of Clinical Microbiology and Infectious Diseases
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
12th Annual ASM Biodefense and Emerging Infections Meeting
Eravacycline Is Efficacious in a Francisella tularensis-Infected Cynomolgus Monkey Model
Antimicrobial Agents and Chemotherapy
Journal of Medicinal Chemistry
53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Comparative Analysis of Eravacycline (TP-434) by Broth Microdilution and Disk Diffusion
53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
The American Conference on Pharmacometrics Inaugural Meeting
23rd European Congress of Clinical Microbiology and Infectious Diseases
23rd European Congress of Clinical Microbiology and Infectious Diseases
23rd European Congress of Clinical Microbiology and Infectious Diseases
23rd European Congress of Clinical Microbiology and Infectious Diseases
Organic Process Research and Development
Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
11th Annual ASM Biodefense and Emerging Diseases
11th Annual ASM Biodefense and Emerging Diseases
52nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
52nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
In Vitro Activity of TP-271 Against Mycobacterium abscessus, M fortuitum, and Nocardia Species
Antimicrobial Agents and Chemotherapy
Target- and Resistance-Based Mechanistic Studies With TP-434, a Novel Fluorocycline Antibiotic
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry
Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
49th Infectious Diseases Society of America Annual Meeting
51st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
TP-434 Has Potential to Treat Complicated Urinary Tract Infections (cUTI)
51st Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
TP-434 Is Synergistic In Vitro With Amphotericin B, Fluconazole, and Caspofungin Against Candida spp
Infectious Diseases Society of America
21st European Congress of Clinical Microbiology and Infectious Diseases
Broad-Spectrum Fluorocycline TP-434 Has Oral Bioavailability in Humans
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
Target- and Resistance-Based Mechanistic Studies With Fluorocyclines TP-434 and TP-271
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
In Vitro Activity of Fluorocyclines Against Legionella pneumophila
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
TP-271, a Novel Oral Fluorocycline for Community-Acquired Respiratory and Biothreat Pathogens
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
In Vitro Activity of Fluorocyclines Against Legionella pneumophila
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
Fluorocyclines: A New Class of Broad-Spectrum Tetracyclines With Antibacterial Properties
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
TP-434 Is Metabolically Stable and Has Low Potential for Drug-Drug Interactions
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
TP-271, a Novel Oral Fluorocycline for Community-Acquired Respiratory and Biothreat Pathogens
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
Target- and Resistance-Based Mechanistic Studies With Fluorocyclines TP-434 and TP-271
50th Annual Interscience Conference of Antimicrobial Agents and Chemotherapy
50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Pharmacokinetics of TP-434 in Mouse, Rat, Dog, Monkey, and Chimpanzee
50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
In Vitro Activity of Fluorocycline TP-434 Against Panels of Recent Bacterial Clinical Isolates
50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Phase 1 Single- and Multiple-Ascending Dose Studies of a Broad-Spectrum Fluorocycline, TP-434
50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Efficacy of Fluorocycline TP-434 in the Neutropenic Thigh Infection Model Is Predicted by AUC/MIC